Literature DB >> 27744358

Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?

Sen Hee Tay1,2, Anselm Mak1,2.   

Abstract

Neurological and psychiatric syndromes, collectively referred to as NPSLE, occur frequently in SLE. The frequency of NPSLE varies from 21 to 95%; however, only 13-38% of neuropsychiatric (NP) events could be attributable to SLE in the NPSLE SLICC inception cohort. This variability in the frequency of NPSLE is attributable to the low specificity of the ACR case definitions for SLE-attributed NP syndromes, inclusion of minor NP events in the ACR nomenclature, difficulty in ascertainment of NP events and diverse experience of rheumatologists in the clinical assessment of NP events. Making the correct and early attribution of NP events to SLE is important to institute appropriate immunosuppressive treatment for favourable outcomes. Various attribution models using composite decision rules have been developed and used to ascribe NP events to SLE. This review will focus on the various clinical presentations, diagnostic work-up and attributions of the common NPSLE syndromes, including other NP events not included in the ACR nomenclature but which have come to attention in recent years.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  attribution model; diagnosis; neuropsychiatric systemic lupus erythematosus

Mesh:

Year:  2017        PMID: 27744358     DOI: 10.1093/rheumatology/kew338

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

1.  Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.

Authors:  Zhen Tan; Yingbo Zhou; Xiangpei Li; Guosheng Wang; Jinhui Tao; Li Wang; Yan Ma; Xiaomei Li
Journal:  Clin Rheumatol       Date:  2017-11-04       Impact factor: 2.980

Review 2.  Brain abscess caused by Micrococcus luteus in a patient with systemic lupus erythematosus: case-based review.

Authors:  Funda Erbasan
Journal:  Rheumatol Int       Date:  2018-10-29       Impact factor: 2.631

Review 3.  Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus.

Authors:  Alessandra Bortoluzzi; Carlo Alberto Scirè; Marcello Govoni
Journal:  Front Med (Lausanne)       Date:  2018-03-14

Review 4.  Neurological Disease in Lupus: Toward a Personalized Medicine Approach.

Authors:  Sarah McGlasson; Stewart Wiseman; Joanna Wardlaw; Neeraj Dhaun; David P J Hunt
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 8.786

5.  Determination of the Risk Factors Contributing to the Development of Neuropsychiatric Lupus in a Systemic Lupus Erythematosus Cohort.

Authors:  Adegbenga A Bankole; Taskeen R Kazmi; Alyssa R Strazanac
Journal:  Cureus       Date:  2021-12-03

6.  Case Report: Macrophage Activation Syndrome and Widespread Neuroimaging Abnormality in Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Nana Shi; Xiangying Wang; Lixia Zou; Xinghui Yang; Qian Ma; Meiping Lu
Journal:  Front Pediatr       Date:  2021-12-14       Impact factor: 3.418

7.  Autoimmune Rheumatic Diseases Masquerading as Psychiatric Disorders: A Case Series.

Authors:  Jayaprakash Russell Ravan; Sucheta Chatterjee; Pratima Singh; Debashis Maikap; Prasanta Padhan
Journal:  Mediterr J Rheumatol       Date:  2021-06-30

Review 8.  Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.

Authors:  Tao Ming Sim; Anselm Mak; Sen Hee Tay
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

9.  Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.

Authors:  Aline L Meier; Nicolas S Bodmer; Carla Wirth; Lucas M Bachmann; Camillo Ribi; Anne-Katrin Pröbstel; David Waeber; Ilijas Jelcic; Urs C Steiner
Journal:  Lupus       Date:  2021-06-21       Impact factor: 2.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.